University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

JACC. Heart failure, 2213-1779

Journal

1 - 40 out of 40Page size: 50
  1. 2020
  2. Gorter, T. M., van Woerden, G., Rienstra, M., Dickinson, M. G., Hummel, Y. M., Voors, A. A., ... van Veldhuisen, D. J. (2020). Epicardial Adipose Tissue and Invasive Hemodynamics in Heart Failure With Preserved Ejection Fraction. JACC. Heart failure, 8(8), 667-676. https://doi.org/10.1016/j.jchf.2020.06.003
  3. Tromp, J., Voors, A. A., Sharma, A., Ferreira, J. P., Ouwerkerk, W., Hillege, H. L., ... Sama, I. E. (2020). Distinct Pathological Pathways in Patients With Heart Failure and Diabetes. JACC. Heart failure, 8(3), 234-242. https://doi.org/10.1016/j.jchf.2019.11.005
  4. Li, J., Woodward, M., Perkovic, V., Figtree, G. A., Heerspink, H. J. L., Mahaffey, K. W., ... Neal, B. (2020). Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes. JACC. Heart failure, 8(1), 57-66. https://doi.org/10.1016/j.jchf.2019.08.004
  5. 2019
  6. Beusekamp, J. C., Tromp, J., Cleland, J. G. F., Givertz, M. M., Metra, M., O'Connor, C. M., ... van der Meer, P. (2019). Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC. Heart failure, 7(11), 970-979. https://doi.org/10.1016/j.jchf.2019.07.010
  7. PARAGON-HF Investigators, Chandra, A., Vaduganathan, M., Lewis, E. F., Claggett, B. L., Rizkala, A. R., ... Solomon, S. D. (2019). Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction The PARAGON-HF Trial. JACC. Heart failure, 7(10), 862-874. https://doi.org/10.1016/j.jchf.2019.05.015
  8. GENETIC-AF Trial Investigators, Piccini, J. P., Abraham, W. T., Dufton, C., Carroll, I. A., Healey, J. S., ... Connolly, S. J. (2019). Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial. JACC. Heart failure, 7(7), 586-598. https://doi.org/10.1016/j.jchf.2019.04.004
  9. ter Maaten, J. M., & Voors, A. A. (2019). Time to Revisit the Value of Urine Collections in Heart Failure. JACC. Heart failure, 7(5), 392-393. https://doi.org/10.1016/j.jchf.2019.01.015
  10. Martens, P., Dupont, M., Verbrugge, F. H., Damman, K., Degryse, N., Nijst, P., ... Mullens, W. (2019). Urinary Sodium Profiling in Chronic Heart Failure to Detect Development of Acute Decompensated Heart Failure. JACC. Heart failure, 7(5), 404-414. https://doi.org/10.1016/j.jchf.2019.02.011
  11. Wolsk, E., Kaye, D., Komtebedde, J., Shah, S. J., Borlaug, B. A., Burkhoff, D., ... Gustafsson, F. (2019). Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction. JACC. Heart failure, 7(4), 321-332. https://doi.org/10.1016/j.jchf.2019.01.006
  12. Savarese, G., Vedin, O., D'Amario, D., Uijl, A., Dahlstrom, U., Rosano, G., ... Lund, L. H. (2019). Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure. JACC. Heart failure, 7(4), 306-317. https://doi.org/10.1016/j.jchf.2018.11.019
  13. Beldhuis, I. E., Myhre, P. L., Claggett, B., Damman, K., Fang, J. C., Lewis, E. F., ... Desai, A. S. (2019). Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease. JACC. Heart failure, 7(1), 25-32. https://doi.org/10.1016/j.jchf.2018.10.017
  14. 2018
  15. Lam, C. S. P., & Chandramouli, C. (2018). Fat, Female, Fatigued Features of the Obese HFpEF Phenotype. JACC. Heart failure, 6(8), 710-713. https://doi.org/10.1016/j.jchf.2018.06.006
  16. Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., ... Ho, J. E. (2018). The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF. JACC. Heart failure, 6(8), 701-709. https://doi.org/10.1016/j.jchf.2018.05.018
  17. Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., ... McMurray, J. J. V. (2018). Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure. JACC. Heart failure, 6(6), 489-498. https://doi.org/10.1016/j.jchf.2018.02.004
  18. Cerbin, L. P., Ambrosy, A. P., Greene, S. J., Armstrong, P. W., Butler, J., Coles, A., ... Mentz, R. J. (2018). Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC. Heart failure, 6(4), 298-307. https://doi.org/10.1016/j.jchf.2018.01.018
  19. Beverborg, N. G., van Veldhuisen, D. J., & van der Meer, P. (2018). Anemia in Heart Failure Still Relevant? JACC. Heart failure, 6(3), 201-208. https://doi.org/10.1016/j.jchf.2017.08.023
  20. Voors, A. A. (2018). Sense and Sensibility of the Use of NT-proBNP for Eligibility in Clinical Trials. JACC. Heart failure, 6(3), 257-259. https://doi.org/10.1016/j.jchf.2018.01.003
  21. Armstrong, P. W., Roessig, L., Patel, M. J., Anstrom, K. J., Butler, J., Voors, A. A., ... O'Connor, C. M. (2018). A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator The VICTORIA Trial. JACC. Heart failure, 6(2), 96-104. https://doi.org/10.1016/j.jchf.2017.08.013
  22. 2017
  23. Damman, K., & Voors, A. A. (2017). The Fastest Way to the Failing Heart Is Through the Kidneys. JACC. Heart failure, 5(9), 682-683. https://doi.org/10.1016/j.jchf.2017.06.001
  24. Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., ... McMurray, J. J. V. (2017). Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction Rationale and Design of the PARAGON-HF Trial. JACC. Heart failure, 5(7), 471-482. https://doi.org/10.1016/j.jchf.2017.04.013
  25. Tromp, J., Khan, M. A. F., Mentz, R. J., O'Connor, C. M., Metra, M., Dittrich, H. C., ... van der Meer, P. (2017). Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC. Heart failure, 5(7), 507-517. https://doi.org/10.1016/j.jchf.2017.04.007
  26. Mulder, B. A., Van Veldhuisen, D. J., & Rienstra, M. (2017). Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation. JACC. Heart failure, 5(6), 466-467. https://doi.org/10.1016/j.jchf.2017.03.010
  27. O'Connor, C. M., & van Veldhuisen, D. J. (2017). Data Sharing From the Editors' Perspective Our Hope With Limitations. JACC. Heart failure, 5(4), 314-315. https://doi.org/10.1016/j.jchf.2017.02.007
  28. Aimo, A., Vergaro, G., Ripoli, A., Bayes-Genis, A., Pascual Figal, D. A., de Boer, R. A., ... Emdin, M. (2017). Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. JACC. Heart failure, 5(4), 287-296. https://doi.org/10.1016/j.jchf.2016.12.016
  29. Lam, C. S. P., Rienstra, M., Tay, W-T., Liu, L. C. Y., Hummel, Y. M., van der Meer, P., ... Hoendermis, E. S. (2017). Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume. JACC. Heart failure, 5(2), 92-98. https://doi.org/10.1016/j.jchf.2016.10.005
  30. Ambrosy, A. P., Cerbin, L. P., Armstrong, P. W., Butler, J., Coles, A., DeVore, A. D., ... Mentz, R. J. (2017). Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial. JACC. Heart failure, 5(1), 1-13. https://doi.org/10.1016/j.jchf.2016.09.012
  31. 2016
  32. Meems, L. M. G., Brouwers, F. P., Joosten, M. M., Lambers Heerspink, H. J., de Zeeuw, D., Bakker, S. J. L., ... de Boer, R. A. (2016). Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population-based cohort study. JACC. Heart failure, 3(3), 189-197. https://doi.org/10.1002/ehf2.12089
  33. Testani, J. M., & ter Maaten, J. M. (2016). Decongestion in Acute Heart Failure Does the End Justify the Means? JACC. Heart failure, 4(7), 589-590. https://doi.org/10.1016/j.jchf.2016.03.024
  34. Pang, P. S., Teerlink, J. R., Voors, A. A., Ponikowski, P., Greenberg, B. H., Filippatos, G., ... Metra, M. (2016). Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes An Exploratory Analysis From the RELAX-AHF Trial. JACC. Heart failure, 4(7), 591-599. https://doi.org/10.1016/j.jchf.2016.02.009
  35. Zipes, D. P., Neuzil, P., Theres, H., Caraway, D., Mann, D. L., Mannheimer, C., ... DEFEAT-HF Trial Investigators (2016). Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure The DEFEAT-HF Study. JACC. Heart failure, 4(2), 129-136. https://doi.org/10.1016/j.jchf.2015.10.006
  36. Tang, W. H. W., Wu, Y., Grodin, J. L., Hsu, A. P., Hernandez, A. F., Butler, J., ... Starling, R. C. (2016). Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure. JACC. Heart failure, 4(1), 68-77. https://doi.org/10.1016/j.jchf.2015.07.015
  37. 2015
  38. Voors, A. A., & ter Maaten, J. M. (2015). Tackling Early Heart Failure Deaths and Readmissions by Estimating Congestion. JACC. Heart failure, 3(11), 894-895. https://doi.org/10.1016/j.jchf.2015.06.013
  39. Grodin, J. L., Perez, A. L., Wu, Y., Hernandez, A. F., Butler, J., Metra, M., ... Tang, W. H. W. (2015). Circulating Kidney Injury Molecule-1 Levels in Acute Heart Failure Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). JACC. Heart failure, 3(10), 777-785. https://doi.org/10.1016/j.jchf.2015.06.006
  40. Davison, B. A., Metra, M., Cotter, G., Massie, B. M., Cleland, J. G. F., Dittrich, H. C., ... PROTECT & RELAX-AHF Executive Comm (2015). Worsening Heart Failure Following Admission for Acute Heart Failure A Pooled Analysis of the PROTECT and RELAX-AHF Studies. JACC. Heart failure, 3(5), 395-403. https://doi.org/10.1016/j.jchf.2015.01.007
  41. Felker, G. M., Butler, J., Collins, S. P., Cotter, G., Davison, B. A., Ezekowitz, J. A., ... Pang, P. S. (2015). Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor Rationale and Design of the BLAST-AHF Study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). JACC. Heart failure, 3(3), 193-201. https://doi.org/10.1016/j.jchf.2014.09.008
  42. Tang, W. H. W., Dupont, M., Hernandez, A. F., Voors, A. A., Hsu, A. P., Felker, G. M., ... Starling, R. C. (2015). Comparative Assessment of Short-Term Adverse Events in Acute Heart Failure With Cystatin C and Other Estimates of Renal Function: Results From the ASCEND-HF Trial. JACC. Heart failure, 3(1), 40-49. https://doi.org/10.1016/j.jchf.2014.06.014
  43. 2013
  44. Damman, K., Masson, S., Hillege, H. L., Voors, A. A., van Veldhuisen, D. J., Rossignol, P., ... Latini, R. (2013). Tubular Damage and Worsening Renal Function in Chronic Heart Failure. JACC. Heart failure, 1(5), 417-424. https://doi.org/10.1016/j.jchf.2013.05.007
  45. de Boer, R. A., Cao, Q., Postmus, D., Damman, K., Voors, A. A., Jaarsma, T., ... Sillje, H. H. W. (2013). The WAP Four-Disulfide Core Domain Protein HE4: A Novel Biomarker for Heart Failure. JACC. Heart failure, 1(2), 164-169. https://doi.org/10.1016/j.jchf.2012.11.005
  46. Rienstra, M., Damman, K., Mulder, B. A., Van Gelder, I. C., McMurray, J. J. V., & Van Veldhuisen, D. J. (2013). Beta-Blockers and Outcome in Heart Failure and Atrial Fibrillation A Meta-Analysis: a meta-analysis. JACC. Heart failure, 1(1), 21-28. https://doi.org/10.1016/j.jchf.2012.09.002
  47. Sanders-van Wijk, S., van Asselt, A. D. I., Rickli, H., Estlinbaum, W., Erne, P., Rickenbacher, P., ... TIME-CHF Investigators (2013). Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure). JACC. Heart failure, 1(1), 64-71. https://doi.org/10.1016/j.jchf.2012.08.002

ID: 14240803

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube